Back
Nuveen Pennsylvania Quality Municipal Income Fund Vs. Avidity Biosciences Industry Stock Comparison
Sell
22
NQP
Nuveen Pennsylvania Quality Municipal Income Fund
Last Price:
$11.01
Seasonality Move:
-2.61%
Buy
57
RNA
Avidity Biosciences
Last Price:
$47.98
Seasonality Move:
-9.33%
Sell
22
Nuveen Pennsylvania Quality Municipal Income Fund (NQP)
is a Sell
Is Nuveen Pennsylvania Quality Municipal Income Fund a Buy, Sell or Hold?
-
The current Nuveen Pennsylvania Quality Municipal Income Fund [NQP] share price is $10.99. The Score for NQP is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.
-
NQP is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
57
Avidity Biosciences (RNA)
is a Buy
Is Avidity Biosciences a Buy, Sell or Hold?
-
The current Avidity Biosciences [RNA] share price is $38.26. The Score for RNA is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
-
RNA is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
NQP Stock Price Chart
What is Nuveen Pennsylvania Quality Municipal Income Fund's stock price today?
-
The Nuveen Pennsylvania Quality Municipal Income Fund share price today is $10.99Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NQP is experiencing buying pressure, which is a positive indicator for future bullish movement.
RNA Stock Price Chart
What is Avidity Biosciences's stock price today?
-
The Avidity Biosciences share price today is $38.26Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RNA is experiencing buying pressure, which is a positive indicator for future bullish movement.
NQP Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 2.87 | Buy |
Relative Strength Index (14 RSI): | 54.64 | Buy |
Chaikin Money Flow: | 18079 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (10.8 - 11.12) | Buy |
Bollinger Bands (100): | (10.94 - 11.28) | Sell |
RNA Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 9.78 | Buy |
Relative Strength Index (14 RSI): | 67.21 | Buy |
Chaikin Money Flow: | 1628766 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (30.49 - 36.11) | Buy |
Bollinger Bands (100): | (27.94 - 33.9) | Buy |
NQP Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 10.87 | Buy |
20-day SMA: | 10.9 | Buy |
50-day SMA: | 11.01 | Sell |
200-day SMA: | 11.38 | Sell |
8-day EMA: | 8.5 | Buy |
20-day EMA: | 4.92 | Buy |
50-day EMA: | 2.32 | Buy |
200-day EMA: | 0.63 | Buy |
RNA Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 36.49 | Buy |
20-day SMA: | 34.37 | Buy |
50-day SMA: | 32.33 | Buy |
200-day SMA: | 33.72 | Buy |
8-day EMA: | 28.9 | Buy |
20-day EMA: | 16.68 | Buy |
50-day EMA: | 7.87 | Buy |
200-day EMA: | 2.15 | Buy |
Nuveen Pennsylvania Quality Municipal Income Fund Earnings Growth & NQP Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Avidity Biosciences Earnings Growth & RNA Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.31 per share, a decrease next quarter of $0.15 per share, a decrease this year of $1.09 per share, and a decrease next year of $0.45 per share.
Nuveen Pennsylvania Quality Municipal Income Fund Technical Analysis
Jul 23 | Jul 24 | Jul 25 | Jul 28 | Jul 29 | Jul 30 | Jul 31 | Aug 1 | Aug 4 | Aug 5 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | Aug | |||||||||
23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | 05 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Avidity Biosciences Technical Analysis
Jul 23 | Jul 24 | Jul 25 | Jul 28 | Jul 29 | Jul 30 | Jul 31 | Aug 1 | Aug 4 | Aug 5 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | Aug | |||||||||
23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | 05 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |